---
title: "石四药集团：苯磺酸左氨氯地平片获药品生产注册批件"
description: "智通财经 APP 讯，石四药集团发布公告，本集团已取得中国国家药品监督管理局有关苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的药品生产注册批件，均属于化学药品第 4 类，视同通过一致性评价。苯磺酸左氨氯地平片主要用于高血压、慢性稳定性心绞痛及血管痉挛性心绞痛的治疗，可单独应用或与其他药物联合应用。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261547438.md"
published_at: "2025-10-17T04:10:05.000Z"
---

# 石四药集团：苯磺酸左氨氯地平片获药品生产注册批件

> 智通财经 APP 讯，石四药集团发布公告，本集团已取得中国国家药品监督管理局有关苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的药品生产注册批件，均属于化学药品第 4 类，视同通过一致性评价。苯磺酸左氨氯地平片主要用于高血压、慢性稳定性心绞痛及血管痉挛性心绞痛的治疗，可单独应用或与其他药物联合应用。

智通财经 APP 讯，石四药集团 (02005) 发布公告，本集团已取得中国国家药品监督管理局有关苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的药品生产注册批件，均属于化学药品第 4 类，视同通过一致性评价。

苯磺酸左氨氯地平片主要用于高血压、慢性稳定性心绞痛及血管痉挛性心绞痛的治疗，可单独应用或与其他药物联合应用。

### Related Stocks

- [02005.HK - 石四药集团](https://longbridge.com/zh-CN/quote/02005.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| SSY Group Ltd. Secures Chinese Regulatory Approval for Levamlodipine Besilate Tablets | SSY Group Ltd. has received approval from China's National Medical Products Administration for Levamlodipine Besilate Ta | [Link](https://longbridge.com/zh-CN/news/261547083.md) |
| SSY Group Wins China Approval for New Hypertension Combination Drug | SSY Group Limited has received approval from China's National Medical Products Administration for its Perindopril Argini | [Link](https://longbridge.com/zh-CN/news/271492775.md) |
| 08:01 ETNew "Hypertension Bites" Campaign Urges Adults to Prioritize Blood Pressure Control | The Hypertension Control Alliance has launched the "Hypertension Bites" campaign to raise awareness about the importance | [Link](https://longbridge.com/zh-CN/news/275760090.md) |
| Towa Pharmaceutical (TSE:4553) Margin Firmness Reinforces Defensive Earnings Narrative In Q3 2026 | Towa Pharmaceutical (TSE:4553) reported solid Q3 2026 results with revenue of ¥73.6b and net income of ¥8.9b, reflecting | [Link](https://longbridge.com/zh-CN/news/275991027.md) |
| SSY Group Wins Chinese Government Bid to Supply Medicines to Healthcare Facilities | SSY Group Wins Chinese Government Bid to Supply Medicines to Healthcare Facilities | [Link](https://longbridge.com/zh-CN/news/263006264.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。